Motley Fool – Earnings Transcripts
Full earnings call transcripts from The Motley Fool
Resideo Technologies Inc (REZI) Q4 2025 Earnings Call Transcript
Thomson Reuters reported full‑year 2025 organic revenue growth of 7%, driven by 9% expansion in its core Legal, Corporate and Tax & Accounting segments. Adjusted EBITDA margin rose to 39.2%, a 100‑basis‑point improvement, while free cash flow reached $1.95 billion. The company increased its dividend 10% to $2.62 per share and completed a $1 billion share‑repurchase program, retiring six million shares. GenAI‑enabled products now represent 28% of annualized contract value, underscoring rapid AI adoption across its portfolio.
Brightstar Lottery PLC (BRSL) Q4 2025 Earnings Call Transcript
Brightstar Lottery PLC posted a Q4 2025 GAAP net loss of $14.4 million ($0.12 per share) but generated adjusted distributable earnings of $19.3 million ($0.15 per share). The loan portfolio grew 13% to $2.7 billion, driven by 32 new originations and a record‑high...
Keurig Dr Pepper Inc (KDP) Q4 2025 Earnings Call Transcript
Hershey (HSY) outlined a robust 2026 outlook, targeting 4‑5% net‑sales growth and 30‑35% earnings expansion. Management highlighted a 41% gross‑margin goal, supported by cocoa hedges that sit above current spot prices. The salty‑snacks segment posted 18% organic growth in Q4,...
Jazz Pharmaceuticals PLC (JAZZ) Q4 2025 Earnings Call Transcript
Jazz Pharmaceuticals reported a record $1.126 billion Q3 2025 revenue, propelled by double‑digit growth in its sleep franchise and the successful launch of the rare‑disease drug Modesto. Xywav and Epidiolex sales rose 11% and 20% year‑over‑year, while oncology product Zepzelca saw an...
Enviri Corp (NVRI) Q4 2025 Earnings Call Transcript
Mirion Technologies reported record 2025 orders exceeding $1.1 billion, a 26% year‑over‑year increase, driven by strong nuclear power demand and a $150 million large‑opportunity pipeline. Revenue rose 7.5% to $925.4 million, with adjusted EBITDA up 12% to $227.9 million and free cash flow doubling...
Cytokinetics Inc (CYTK) Q4 2025 Earnings Call Transcript
Cytokinetics announced rapid global regulatory clearance for MYCorzo, securing FDA, China NMPA, and European Commission approvals within a single week. The company launched the drug in the U.S. with over 700 REMS‑certified physicians and more than 12,000 customer engagements in...
Clean Energy Fuels Corp (CLNE) Q4 2025 Earnings Call Transcript
Clean Energy Fuels reported adjusted EBITDA of $67.6 million for 2025, topping the high end of its $65 million guidance despite the loss of alternative fuel tax credits. GAGA loss widened to $222 million, mainly from non‑cash interest charges tied...
Gladstone Land Corp (LAND) Q4 2025 Earnings Call Transcript
Gladstone Investment Corp reported a NAV increase to $14.95 per share, driven by $1.77 per share of unrealized appreciation and $0.09 per share of realized gains. Adjusted net investment income fell to $0.21 per share, while total assets rose to...
Fidelity National Information Services Inc (FIS) Q4 2025 Earnings Call Transcript
Fidelity National Information Services (FIS) posted Q4 2025 adjusted revenue of $2.7 billion, up 6.3% year‑over‑year, and lifted its full‑year revenue growth outlook to 5.4‑5.7%. Adjusted EBITDA margin expanded to 41.8% with a sequential 200‑basis‑point improvement, while free cash flow conversion...
Orthofix Medical Inc (OFIX) Q4 2025 Earnings Call Transcript
Orthofix Medical reported fourth‑quarter 2020 net sales of $118 million, a 3% decline year‑over‑year but a 6% sequential increase. Spine implant revenue grew 9% YoY, propelled by an 11% rise in U.S. M6 disc sales, while motion‑preservation revenue jumped 129% YoY....
Hyliion Holdings Corp (HYLN) Q4 2025 Earnings Call Transcript
Herc Holdings reported a transformative fourth‑quarter 2025, with equipment rental revenue climbing 24% year‑over‑year after the June H&E acquisition and strong mega‑project demand. Adjusted EBITDA rose 19% to $2.0‑2.1 billion for 2026 guidance, while used equipment sales surged 53% but pressured...
Planet Fitness Inc (PLNT) Q4 2025 Earnings Call Transcript
Medifast reported Q4 2025 revenue of $75.1 million, down 36.9% year‑over‑year, as the active earning coach base shrank 40.6% to roughly 16,100. Despite the top‑line decline, average revenue per coach increased 6.2% to $4,664, marking the first year‑over‑year productivity gain since...
Bowhead Specialty Holdings Inc (BOW) Q4 2025 Earnings Call Transcript
Bowhead Specialty Holdings reported a strong 2025 finish, with gross written premiums reaching $862.8 million, a 24% increase year‑over‑year, driven primarily by casualty growth. Adjusted net income rose 30% to $55.6 million and the expense ratio slipped below 30% thanks to the...
Harmony Biosciences Holdings Inc (HRMY) Q4 2025 Earnings Call Transcript
Harmony Biosciences reported $714.7 million net product revenue for 2024, a 23% year‑over‑year increase, with Q4 sales of $201.3 million driven largely by its flagship narcolepsy drug Wakix. The company announced a generic settlement with Novogen that postpones competition until at least...
Leonardo DRS Inc (DRS) Q4 2025 Earnings Call Transcript
Leonardo DRS reported Q2 FY2025 revenue of $829 million, up 10% year‑over‑year, and adjusted EBITDA of $96 million, expanding margin to 11.6%. Bookings reached $853 million with a 1.0 book‑to‑bill ratio and total backlog grew 9% to $8.6 billion. The company raised its full‑year...
Cipher Mining Inc (CIFR) Q4 2025 Earnings Call Transcript
Chimera Investment Corporation reported Q4 2025 GAAP net income of $7 million ($0.08 per share) and a full‑year profit of $144 million. The board increased the quarterly dividend 22% to $0.45 and signaled it will remain at that level through 2026. Integration...
Henry Schein Inc (HSIC) Q4 2025 Earnings Call Transcript
Henry Schein reported $3.4 billion in Q4 2025 sales, a 7.7% increase and the strongest growth in over three years. Non‑GAAP operating margin held at 7.42% while cash flow from operations jumped to $381 million. Cloud‑based Dentrix Ascend reached over 11,000 subscribers,...
Xenia Hotels & Resorts Inc (XHR) Q4 2025 Earnings Call Transcript
Xenia Hotels & Resorts reported a Q3 2025 net loss of $13.7 million while generating $42.2 million of adjusted EBITDAre and 23 cents adjusted FFO per share, an 8% YoY decline. Same‑property RevPAR was flat, but excluding the Houston market the portfolio saw...
Talos Energy Inc (TALO) Q4 2025 Earnings Call Transcript
Talos Energy reported adjusted EBITDA of $294 million and adjusted free cash flow of $99 million for the quarter, driven by cost‑saving initiatives and strong operational performance. Average production reached 93,300 barrels of oil equivalent per day, with oil comprising 69% of...
Perfect Corp (PERF) Q4 2025 Earnings Call Transcript
Procore Technologies reported Q4 FY2025 revenue of $349 million, a 15.6% year‑over‑year increase, and a non‑GAAP operating margin of 15%. The company added 2,700 $100,000‑plus ARR customers, now representing 66% of total ARR, and saw free cash flow rise 69% to...
Slide Insurance Holdings Inc (SLDE) Q4 2025 Earnings Call Transcript
National MI Holdings reported a record 2025 year, posting $388.9 million net income (up 8%), diluted EPS of $4.92 (up 11%), and a 16.2% return on equity. Insurance in force reached $221.4 billion, while fourth‑quarter new insurance written hit $14.2 billion, driving total...
International General Insurance Holdings Ltd (IGIC) Q4 2025 Earnings Call Transcript
International General Insurance Holdings (IGIC) posted Q3 2025 net income of $33.5 million and $94.9 million for the first nine months, delivering a 20% annualized return on equity. The company saw gross premiums written dip 5% in Q3, driven by long‑tail pressure,...
Iovance Biotherapeutics Inc (IOVA) Q4 2025 Earnings Call Transcript
Iovance Biotherapeutics reported third‑quarter product revenue of about $68 million, a 13% sequential increase, driven primarily by $58 million in Amtagvi sales and $10 million in Proleukin revenue. Gross margin improved to roughly 43% after a restructuring that cut cost of sales by...
Solaris Energy Infrastructure Inc (SEI) Q4 2025 Earnings Call Transcript
Solaris Energy Infrastructure announced a major upsizing of its core power‑solutions contract to 900 MW with a seven‑year tenor, extending earnings visibility to 2033. The joint‑venture, in which Solaris holds a 50.1% stake, is fully financed by a $550 million senior secured...
Westlake Chemical Partners LP (WLKP) Q4 2025 Earnings Call Transcript
Westlake Chemical Partners reported Q3 2025 net income of $15 million ($0.42 per unit) and consolidated net sales of $3.09 billion, reflecting the completion of the Petro 1 ethylene unit turnaround. Distributable cash flow matched earnings at $15 million but fell $3 million short of...
Huron Consulting Group Inc (HURN) Q4 2025 Earnings Call Transcript
Huron Consulting Group reported record third‑quarter 2025 revenues, with RBR reaching $432.4 million, a 16.8% year‑over‑year increase. The Healthcare segment drove growth, posting a 19.9% rise in RBR and expanding operating‑income margin to 30.9%. Adjusted earnings per share climbed 25% to...
CCC Intelligent Solutions Holdings Inc (CCC) Q4 2025 Earnings Call Transcript
CTS Corporation reported fourth‑quarter 2025 revenue of $137 million, a 9% year‑over‑year increase, with diversified end markets now contributing 59% of total sales. The medical segment surged, posting a 41% quarterly sales jump and a 37% rise in bookings, while the...
Interface Inc (TILE) Q4 2025 Earnings Call Transcript
Interface Inc. reported third‑quarter net sales of $364.5 million, a 5.9% increase year over year and 4.2% on a currency‑neutral basis. Adjusted gross profit margin rose 208 basis points to 39.5%, while adjusted operating income grew 24.5% to $54.1 million and EPS...
Fulcrum Therapeutics Inc (FULC) Q4 2025 Earnings Call Transcript
Fulcrum Therapeutics reported a strong fourth‑quarter, posting $1.51 billion in revenue, a 28% year‑over‑year increase, and a full‑year 2025 revenue of $5.14 billion, up 21%. Core product sales accelerated, led by Jakafi’s $828 million Q4 revenue and Opsilura’s 28% sales jump to $207 million....
Lucid Group Inc (LCID) Q4 2025 Earnings Call Transcript
Lucid Group reported a record 2024 with 9,029 vehicles produced and 10,241 deliveries, a 71% year‑over‑year increase. GAAP gross margin narrowed to –114% from –225% a year earlier, signaling improving cost structure. The new Lucid Gravity SUV generated strong order...
Adapthealth Corp (AHCO) Q4 2025 Earnings Call Transcript
American Well Corp (AHCO) reported Q4 2025 revenue of $55.3 million, a 22.1% YoY decline, as the company completed its pivot from a multi‑product telehealth provider to a pure SaaS platform. Subscription revenue now represents 53% of total revenue, reflecting...
Supernus Pharmaceuticals Inc (SUPN) Q4 2025 Earnings Call Transcript
Vanda Pharmaceuticals reported a 9% rise in total revenue to $216.1 million for 2025, driven primarily by a 24% jump in Fanapt sales and a successful bipolar disorder launch. The company secured FDA approval for tradipitant (Nirius) for motion‑sickness prevention, marking...
Xometry Inc (XMTR) Q4 2025 Earnings Call Transcript
Xometry Inc. reported fourth‑quarter 2025 revenue of $2 billion, a 5% year‑over‑year increase, driven by modest LTL growth and higher yields. Adjusted EBITDA rose 11% to $312 million, with the LTL segment contributing $285 million, while adjusted diluted EPS climbed 18% to $0.88....
Par Pacific Holdings Inc (PARR) Q4 2025 Earnings Call Transcript
Par Pacific Holdings reported Q3 2025 adjusted EBITDA of $372 million, largely driven by a $200 million boost from small refinery exemptions. Throughput reached a near‑record 198,000 barrels per day and system‑wide production costs fell to a record low $6.13 per barrel....
Option Care Health Inc (OPCH) Q4 2025 Earnings Call Transcript
Centene reported full‑year 2025 adjusted diluted EPS of $2.08 and a Q4 loss of $1.19 per share, impacted by a $389 million Magellan divestiture charge. Management forecast 2026 adjusted EPS above $3, implying more than 40% year‑over‑year growth, driven by Medicaid...
Globus Medical Inc (GMED) Q4 2025 Earnings Call Transcript
Globus Medical reported a record $2.519 billion revenue for 2024, up 61% year‑over‑year, and a non‑GAAP EPS of $3.04, a 31% increase. Free cash flow surged 145% to $405 million, allowing the company to eliminate its remaining $1 billion merger debt by Q1 2025....
Life Time Group Holdings Inc (LTH) Q4 2025 Earnings Call Transcript
Life Time Group Holdings reported Q2 2025 revenue of $761 million, up 14% year‑over‑year, driven by higher membership dues, enrollment fees, and incentive revenue. Net income rose 36.5% to $72.1 million, while adjusted EBITDA reached $211 million with a 27.7% margin, reflecting strong...
Camping World Holdings Inc (CWH) Q4 2025 Earnings Call Transcript
CTS Corporation reported fourth‑quarter 2025 revenue of $137 million, a 9% year‑over‑year increase, while sequentially falling 4%. Diversified end markets now represent 59% of total revenue, growing 16% YoY, driven by strong medical (+41% Q4) and industrial (+16% Q4) performance. Adjusted...
Evolent Health Inc (EVH) Q4 2025 Earnings Call Transcript
Evolent Health reported $2.55 billion in 2024 revenue, a 30% year‑over‑year increase, with adjusted EBITDA of $160.5 million landing at the low end of its guidance due to elevated oncology costs. The company announced two major contracts—a New England health plan covering...
Tanger Inc (SKT) Q4 2025 Earnings Call Transcript
TPG reported record Q4 2025 results, posting GAAP net income of $77 million and after‑tax distributable earnings of $304 million, or $0.71 per share. The firm raised a record $51 billion in capital in 2025, a 71% increase, and deployed a record $19 billion...
CAVA Group Inc (CAVA) Q4 2025 Earnings Call Transcript
CAVA Group reported a 20% year‑over‑year revenue increase to $289.8 million in Q4 2025, driven by strong same‑restaurant sales growth of 1.9% and the opening of 17 net new locations, bringing the total to 415 restaurants. Restaurant‑level profit margin expanded to...
First Watch Restaurant Group Inc (FWRG) Q4 2025 Earnings Call Transcript
Restaurant Brands International reported 2.4% comparable sales growth and 5.3% system‑wide sales increase for 2025, delivering 8.3% organic adjusted operating income growth and a 10.7% rise in adjusted EPS to $3.69. Net restaurant growth slowed to 2.9%, the lowest point...
EOG Resources Inc (EOG) Q4 2025 Earnings Call Transcript
EOG Resources reported a record $4.7 billion free cash flow for 2025, returning 100% of that amount to shareholders through an 8% dividend increase and $2.5 billion of share repurchases. The company cut well costs by 7% by extending lateral lengths and...
Ceribell Inc (CBLL) Q4 2025 Earnings Call Transcript
Ceribell reported a 34% year‑over‑year revenue increase to $24.8 million in Q4 2025, reaching $89.1 million for the full year. Gross margins remained high at 87% for the quarter, with a cash balance of $159.3 million, while net loss widened to $13.5 million due...
Innovex International Inc (INVX) Q4 2025 Earnings Call Transcript
Innovex International reported Q2 2025 revenue of $224 million, up 72% year‑over‑year but down 7% sequentially, as international and offshore sales slipped 13% amid Middle East and Asia‑Pacific headwinds. Adjusted EBITDA rose to $47 million, lifting the margin to 21% while free...
Tarsus Pharmaceuticals Inc (TARS) Q4 2025 Earnings Call Transcript
Tarsus Pharmaceuticals reported record 2025 net product sales of $451.4 million, driven by XDEMVY adoption, and issued its first full‑year 2026 guidance forecasting $670‑$700 million, implying over 50% revenue growth. The company highlighted a 44% gross‑to‑net discount, a robust DTC campaign that...
Allison Transmission Holdings Inc (ALSN) Q4 2025 Earnings Call Transcript
Allison Transmission reported Q4 2025 net sales of $737 million, a 7% year‑over‑year decline, while adjusted EBITDA margin improved to 36%, up 200 basis points. Net income fell sharply to $99 million due to a $29 million electrification impairment and $26 million acquisition costs,...
Backblaze Inc (BLZE) Q4 2025 Earnings Call Transcript
BlackLine reported Q4 2025 revenue of $183 million, an 8% increase year‑over‑year, and total ARR of $702 million, up nearly 10%. Bookings surged 22% to a record level, with three‑quarters coming from existing customers, while platform pricing adoption rose to 11% of...
Axsome Therapeutics Inc (AXSM) Q4 2025 Earnings Call Transcript
Axsome Therapeutics reported a 66% revenue surge to $639 million in 2025, driven by strong growth in Auvelity, Sunosi and the newly launched Cymbravo. Net loss narrowed to $183 million, a 35% improvement year‑over‑year, while cash rose to $323 million. The company secured...
BWX Technologies Inc (BWXT) Q4 2025 Earnings Call Transcript
BWX Technologies reported $866 million revenue for the quarter, a 29% year‑over‑year increase, propelled by strong performance in both government and commercial segments. The company’s backlog surged to $7.4 billion, up 119% YoY, delivering a book‑to‑bill ratio of 2.6. Commercial operations exploded...